- Home
- EXEL vs DCI Comparison
EXEL vs DCI Comparison
Compare EXEL & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | DCI |
|---|---|---|
| Founded | 1994 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pollution Control Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.3B |
| IPO Year | 2000 | 2005 |
Fundamental Metrics
Financial Performance| Metric | EXEL | DCI |
|---|---|---|
| Price | $70.52 | $85.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 8 |
| Target Price | $59.79 | ★ $100.40 |
| AVG Volume (30 Days) | ★ 2.3M | 496.1K |
| Earning Date | 10-29-2026 | 12-03-2026 |
| Dividend Yield | N/A | ★ 1.54% |
| EPS Growth | ★ 57.95 | 26.23 |
| EPS | 2.46 | ★ 3.85 |
| Revenue | $452,477,000.00 | ★ $2,844,900,000.00 |
| Revenue This Year | $10.16 | $7.86 |
| Revenue Next Year | $12.43 | $4.88 |
| P/E Ratio | $28.34 | ★ $21.56 |
| Revenue Growth | N/A | ★ 4.05 |
| 52 Week Low | $37.58 | $79.61 |
| 52 Week High | $72.10 | $112.84 |
Technical Indicators
Market Signals| Indicator | EXEL | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 83.32 | 44.78 |
| Support Level | $54.85 | $82.69 |
| Resistance Level | N/A | $88.42 |
| Average True Range (ATR) | 1.80 | 1.64 |
| MACD | 0.59 | -0.18 |
| Stochastic Oscillator | 87.36 | 46.39 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.9 billion in revenue in its fiscal year 2026.